Blood thinner apixaban tested in Over-80s: bleeding risks and benefits revealed
NCT ID NCT04586972
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 25 times
Summary
This study followed nearly 1,000 people aged 80 and older with atrial fibrillation who were newly prescribed apixaban, a blood thinner to prevent strokes. Researchers tracked how many had bleeding events and whether the dose was appropriate. The goal was to see how well the drug works and how safe it is in this very old, often frail population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONVALVULAR ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Geriatric Department, Broca Hospital
Paris, IIe-de-France, 75013, France
Conditions
Explore the condition pages connected to this study.